Perricone, Ugo
 Distribuzione geografica
Continente #
NA - Nord America 1.151
EU - Europa 504
AS - Asia 150
AF - Africa 10
SA - Sud America 5
OC - Oceania 1
Totale 1.821
Nazione #
US - Stati Uniti d'America 1.148
IT - Italia 263
CN - Cina 120
IE - Irlanda 68
FI - Finlandia 40
DE - Germania 39
GB - Regno Unito 22
RU - Federazione Russa 15
IN - India 11
DZ - Algeria 10
BE - Belgio 8
SE - Svezia 8
FR - Francia 6
PL - Polonia 6
RS - Serbia 6
TW - Taiwan 6
RO - Romania 5
AR - Argentina 4
AT - Austria 4
CA - Canada 3
GR - Grecia 3
UA - Ucraina 3
DK - Danimarca 2
ES - Italia 2
ID - Indonesia 2
IR - Iran 2
PK - Pakistan 2
AU - Australia 1
BR - Brasile 1
HK - Hong Kong 1
IL - Israele 1
JP - Giappone 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
NL - Olanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 1.821
Città #
Fairfield 156
Chandler 129
Ashburn 123
Ann Arbor 96
Woodbridge 84
Palermo 76
Seattle 71
Dublin 68
Wilmington 63
Houston 60
Cambridge 53
Medford 28
Nanjing 27
Princeton 20
New York 19
Altamura 16
Dearborn 15
Lawrence 15
Beijing 12
Prato 11
San Diego 11
Washington 11
Messina 10
Milan 10
Hebei 9
Shenyang 9
Zhengzhou 9
Brussels 8
Des Moines 8
Jinan 8
Ludwigshafen am Rhein 8
Rome 8
Changsha 7
Helsinki 7
Jiaxing 7
Boardman 6
Tianjin 6
Nanchang 5
Redwood City 5
San Paolo di Civitate 5
Taizhou 5
Cagliari 4
Kumar 4
Mila 4
Tulsa 4
Venice 4
Atlanta 3
Catania 3
Cefalù 3
Hangzhou 3
Hanover 3
Kaohsiung 3
La Plata 3
London 3
Ningbo 3
Saint Petersburg 3
Aarhus 2
Annandale 2
Annecy-le-vieux 2
Chicago 2
Chieti 2
Düsseldorf 2
Frankfurt 2
Gorzków 2
Islamabad 2
Jijelli 2
Kilburn 2
Manfredonia 2
Monzambano 2
Nagold 2
Napoli 2
Polska 2
San Giorgio A Cremano 2
San Jose 2
Southwark 2
Thessaloníki 2
Andover 1
Aosta 1
Appleton 1
Augusta 1
Belgrade 1
Berlin 1
Bethesda 1
Bologna 1
Bremen 1
Caulonia 1
Chaoyang 1
Chisinau 1
Chiswick 1
Cluj-napoca 1
Council Bluffs 1
Damaslawek 1
Derio 1
Foggia 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Groningen 1
Guangzhou 1
Haikou 1
Totale 1.418
Nome #
Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery 158
Development and optimisation of computational tools for drug discovery 155
The Repurposing of Old Drugs or Unsuccessful Lead Compounds by in Silico Approaches: New Advances and Perspectives 132
Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations 128
Does ligand symmetry play a role in the stabilization of DNA g-quadruplex host-guest complexes? 127
Synthesis, antiproliferative activity, and in silico insights of new 3-benzoylamino-benzo[ b ]thiophene derivatives 119
Micelles of the chiral biocompatible surfactant (1R,2S)-dodecyl-(2-hydroxy-1-methyl-2-phenylethyl)dimethylammonium bromide (DMEB): Molecular dynamics and fragmentation patterns in the gas phase 119
Conf-VLKA: A structure-based revisitation of the Virtual Lock-and-key Approach 117
Micelles, Rods, Liposomes, and Other Supramolecular Surfactant Aggregates: Computational Approaches 109
Design, synthesis and preliminary evaluation of dopamine-amino acid conjugates as potential D1 dopaminergic modulators 108
Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling/docking approach 99
A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α 94
An overview of recent molecular dynamics applications as medicinal chemistry tools for the undruggable site challenge 94
2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by interaction with NMDA receptor 84
Evaluating The Stability of Pharmacophore Features Using Molecular Dynamic Simulations 75
A computational study to explore the molecular mechanisms behind the antiproliferative activity of Nortopsentin derivatives 64
A convolutional neural network for virtual screening of molecular fingerprints 61
MOLECULAR DYNAMICS - MULTIPLE RECEPTOR CONFORMATIONS APPROACH TO ENHANCE STRUCTURE-BASED VIRTUAL SCREENING ON PPAR-alpha RECEPTOR 59
A dynamic multiple receptor conformations (MD-MRC) approach to enhance early enrichment in virtual screening. A case study on PPAR-alpha 44
A dynamic-common pharmacophore approach to improve virtual screening. A case study on PPAR-alpha 36
Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome 10
Non-covalent immunoproteasome inhibitors: virtual screening and in vitro test on β1i /β5i subunits 6
Exploring the new non-covalent immunoproteasome inhibitors of β1i /β5i subunits: Virtual screening and in vitro test 5
null 3
PRC2 allosteric modulation an alternative strategy in drug discovery for the epigenetic diseases 1
Totale 2.007
Categoria #
all - tutte 6.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201992 0 0 0 0 0 0 0 0 0 12 33 47
2019/2020424 47 15 10 32 42 64 50 36 47 24 45 12
2020/2021278 13 29 8 18 16 10 14 32 48 46 18 26
2021/2022260 20 48 6 6 2 9 8 13 26 29 33 60
2022/2023354 32 66 16 31 34 57 10 27 44 12 14 11
2023/2024189 5 21 17 24 16 60 16 13 0 17 0 0
Totale 2.007